Related Experiment Video
Updated: Jul 16, 2025
10:39
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
18.3K
Migraine headache: When to consider these newer agents
Emily Peterson1, Allison Bernard1, Robert A Beck1
1Department of Family Medicine, University of Iowa Hospitals and Clinics, Iowa City.
The Journal of Family Practice
|September 20, 2023
Summary
New therapeutic agents offer comparable effectiveness to traditional treatments for acute and preventive care. These novel options also present fewer adverse effects and can streamline patient treatment plans.
Area of Science:
- Pharmacology
- Therapeutics
Background:
- Traditional treatments for acute and preventive care have established efficacy.
- Adverse effects and complex regimens can impact patient adherence and outcomes.
Purpose of the Study:
- To evaluate novel therapeutic agents for acute and preventive care.
- To compare the efficacy, safety, and regimen simplicity of these agents against traditional treatments.
Main Methods:
- Comparative analysis of therapeutic agents.
- Assessment of efficacy in acute and preventive settings.
- Evaluation of adverse effect profiles and regimen complexity.
Main Results:
- The evaluated agents demonstrate effectiveness on par with traditional treatments.
- These agents are associated with a reduced incidence of adverse effects.
- Implementation of these agents can lead to simplified treatment regimens.
Conclusions:
- Novel therapeutic agents provide a viable alternative to traditional treatments.
- These agents offer improved safety profiles and enhanced patient convenience.
- The findings support the integration of these agents into clinical practice for acute and preventive care.
Related Concept Videos
01:23Antidepressant Drugs: MAOIs and Other Agents
270
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
270
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
237
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
237
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
200
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
200
01:25Antidepressant Drugs: Overview
555
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
555
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
190
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
190
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
326
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
326